Thought leadership and market insights
How biotech companies can get started with AI
Many biotech companies recognise the transformative potential of AI but struggle to leverage it effectively in their drug discovery processes. In this perspective, we outline two key approaches for companies to assess the strategic fit of AI in their pipeline: identifying value-adding AI initiatives and conducting a maturity assessment. By pinpointing where AI can deliver measurable value and evaluating organisational readiness, companies can make well-informed decisions and phase AI adoption to minimise risk and maximise potential for innovation.
How biotech companies can get started with AI
Please enter your name and email to download the article.
How life science companies can realize the value of omnichannel investments
Despite large investments in omnichannel capabilities, many life science companies have yet to see the results predicted in business cases. In this perspective, we describe how an integrated bundle of technological, commercial, and transformational capabilities combined with deliberate strategic choices will increase the odds of a successful and sustainable transformation and enable full omnichannel value realization.
How life science companies can realize the value of omnichannel investments
Please enter your name and email to download the article.
.jpg)
How strategy helps biotech CEOs address key challenges in scaling
A good strategy is both actionable and practical. It lays a clear direction for execution that enables distributed decision making and allows the entire organization to act with strategic intent. It ensures stronger execution and better use of resources. In this perspective on strategy for biotechs, we demonstrate how typical challenges faced by CEOs in small and medium-sized biotech companies can be proactively addressed through better strategy.
How strategy helps biotech CEOs address key challenges in scaling
Please enter your name and email to download the article.
